To Evaluate the Safety and Efficacy for GORE TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Disease

Study Type: Interventional Study Design: Treatment, Open Label, Uncontrolled, Single Group Assignment, Safety and Efficacy study Official Title: A Clinical Study of the TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Diseases for Non-Surgical Candidates under the Physician Sponsored IDE. PURPOSE OF RESEARCH: You are invited to participate in a research study for treatment of aneurysms of the descending thoracic aorta. The investigational device, called the TAG Thoracic Endoprosthesis (device) has been designed to simplify treatment of aneurysms of the descending thoracic aorta. The other pathologies treated can include pseudoaneurysms, acute and chronic dissections, penetrating ulcers, mycotic aneurysms, ruptures, fistulae, and transections.The device is made from a graft (an artificial vessel) which is surrounded on the outside by a metal mesh-like form. The device is in the shape of a tube. The device reinforces the weakened part of the aorta from the inside. Blood flows through the device to the arteries that go to your abdomen and legs. The device is folded tightly onto a catheter (a flexible, hollow tube) that is put into the aorta through an artery in your leg. Unless there is a problem, you would not need to have your chest opened.

Principal Investigator

  • Daniel Sze, MD, PhD

Stanford Investigator(s)

  • Michael Fischbein
  • D. Craig Miller, M.D.
  • R. Scott Mitchell
  • John D. Louie, MD
  • WILLIAM T. KUO, MD, FSIR, FCCP, FSVM, FCIRSE
  • Nishita Kothary, MD
  • Lawrence "Rusty" Hofmann, MD
  • David Hovsepian, MD

CONTACT INFORMATION

Primary Contact:
Archana Verma
(650) 736-0959

View on ClinicalTrials.gov